Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabien Tech. Regulatory News (SNT)

Share Price Information for Sabien Tech. (SNT)

Share Price is delayed by 15 minutes
Get Live Data
3.25    0.00 (0.00%)
Bid:
3.00
Ask:
3.50
Spread: 0.50 (16.667%)
Market Cap: £1.03m
SNT Live PriceLast checked at - London Stock Exchange

Intraday Sabien Tech. Share Chart

Placing

14 Oct 2009 07:00

RNS Number : 7162A
Sabien Technology Group PLC
14 October 2009
 



14 October 2009

Sabien Technology Group plc

("Sabien" or "the Company")

GBP1.475 million Placing

Placing of 4,916,000 Ordinary Shares at 30 pence per share to raise  approximately  GBP1.475 million from institutional and other investors

Placing to support the Company's growth and working capital requirements

Funds raised will also allow the Company to repay the TVI 2 Limited ("TVI 2") loan early thereby reducing the number of warrants issued to TVI 2 from 2,952,279 to 1,518,356 and leaving the Company debt free

Sabien, the manufacturer and supplier of M2G, an energy efficiency technology, is pleased to announce that it has conditionally placed 4,916,000 new ordinary shares of 5 pence each (the "Placing Shares") at a price of 30 pence per share (the "Placing Price"), raising approximately GBP1.475 million (before  expenses) for the Company from a number of institutional and other investors (the "Placing") through Arbuthnot Securities.

The funds raised from the Placing will provide Sabien with the capital necessary to support the  Company's working capital requirements and will allow it to continue to grow its prospective pipeline  for the installation of M2G devices, which currently stands at c. 3,000 devices

The Placing Shares have been conditionally placed with institutional and other investors by Arbuthnot Securities Limited. The Placing Shares will, when issued, rank pari passu with the Company's existing issued ordinary shares, and dealings are expected to commence in the Placing Shares on Monday19 October 2009 ("Admission"). 

 

Alan O'Brien, Chief Executive Officer for Sabien said:

"I am very pleased by the support we have received from existing and new shareholders. The funds raised through this placing provide Sabien with the resources to pursue its growth strategy in the European and US markets and to repay its loan to TVI 2 leaving the company completely debt free. Early repayment of the TVI 2 loan means that approximately 50 per cent. of the warrants issued to TVI 2 will be cancelled. I would also like to thank all our advisers for a job well done." 

Total Voting Rights

Following Admission, the total number of issued ordinary shares of 5 pence each in the Company (the "Ordinary Shares") will be 31,486,511. The Company does not hold any Ordinary Shares in treasury. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Service Authority's Disclosure and Transparency Rules. 

For further information:

 Sabien Technology Group plc 

 Alan O'Brien, CEO

Tel: +44 (0) 20 7993 3700

 Gus Orchard, CFO

www.sabien-tech.co.uk

Arbuthnot Securities Limited

 Antonio Bossi

Tel: +44 (0) 20 7012 2000

www.arbuthnotsecurities.co.uk

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEILFIRITLVLIA
Date   Source Headline
16th Dec 201912:30 pmRNSIssue of Equity
5th Dec 20194:30 pmRNSResult of AGM
13th Nov 20195:15 pmRNSNotice of AGM
6th Nov 20197:00 amRNSHolding(s) in Company
5th Nov 20197:00 amRNSDirectorate Change
4th Nov 201911:30 amRNSHolding(s) in Company
1st Nov 20191:00 pmRNSHolding(s) in Company
31st Oct 20195:00 pmRNSHolding(s) in Company
29th Oct 201911:05 amRNSSecond Price Monitoring Extn
29th Oct 201911:00 amRNSPrice Monitoring Extension
29th Oct 20199:05 amRNSSecond Price Monitoring Extn
29th Oct 20199:00 amRNSPrice Monitoring Extension
18th Oct 20192:47 pmRNSCorporate Update
30th Sep 20192:37 pmRNSTotal Voting Rights
27th Sep 20197:00 amRNSFinal Results
24th Sep 20197:00 amRNSBoard Changes
20th Sep 201910:51 amRNSHolding(s) in Company
10th Sep 201910:59 amRNSHolding(s) in Company
10th Sep 201910:56 amRNSHolding(s) in Company
3rd Sep 20197:00 amRNSBoard changes, subscription and trading update
28th Jun 20193:38 pmRNSHolding(s) in Company
11th Jun 20191:46 pmRNSNew contract award and trading update
30th May 20197:00 amRNSHolding(s) in Company
13th May 20197:00 amRNSPlacing
2nd Apr 20197:00 amRNSCorporate Update - Contract Win
14th Feb 20197:00 amRNSHalf-year Report
12th Feb 201910:29 amRNSHolding(s) in Company
12th Feb 201910:24 amRNSHolding(s) in Company
12th Feb 201910:24 amRNSHolding(s) in Company
4th Feb 20193:20 pmRNSCorporate Update - Orders Received
17th Jan 20197:00 amRNSDirectorate Change
21st Dec 20182:54 pmRNSResult of AGM and Board change
20th Dec 201810:29 amRNSDirector/PDMR Shareholding
20th Dec 201810:27 amRNSHolding(s) in Company
17th Dec 20183:47 pmRNSHolding(s) in Company
17th Dec 20182:54 pmRNSHolding(s) in Company
17th Dec 20182:50 pmRNSHolding(s) in Company
17th Dec 20182:49 pmRNSHolding(s) in Company
17th Dec 20187:00 amRNSHolding(s) in Company
13th Dec 20182:09 pmRNSResult of General Meeting and Board changes
28th Nov 20185:49 pmRNSNotice of AGM
28th Nov 20185:29 pmRNSAnnual Financial Report
27th Nov 20183:21 pmRNSNotice of GM
23rd Nov 201812:07 pmRNSConditional placing and proposed board changes
19th Nov 20185:47 pmRNSHolding(s) in Company
30th Aug 20184:36 pmRNSResult of Meeting, Change of Registered Office
7th Jun 20187:00 amRNSCorporate Update New Order Received
2nd May 201810:51 amRNSTotal Voting Rights
27th Mar 20184:33 pmRNSPDMR Shareholding
26th Mar 20187:00 amRNSFundraise and appointment of sole broker

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.